David Steinberg
Stock Analyst at Jefferies
(2.84)
# 1,747
Out of 4,863 analysts
35
Total ratings
59.26%
Success rate
20.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $5.91 | +35.36% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $26.69 | +136.04% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $32.47 | +23.19% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $109.64 | +71.47% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $8.75 | -8.52% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $3.99 | +200.75% | 2 | Jun 14, 2018 | |
| SVRA Savara | Initiates: Buy | $20 | $2.18 | +817.43% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $5.91
Upside: +35.36%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $26.69
Upside: +136.04%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $32.47
Upside: +23.19%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $109.64
Upside: +71.47%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $8.75
Upside: -8.52%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $3.99
Upside: +200.75%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $2.18
Upside: +817.43%